Predicting the Response to Combination Antiretroviral Therapy: Retrospective Validation of geno2pheno‐THEO on a Large Clinical Database
Author(s) -
André Altmann,
Martin Däumer,
Niko Beerenwinkel,
Yardena Peres,
Eugen Schülter,
Joachim Büch,
SooYon Rhee,
Anders Sönnerborg,
W. Jeffrey Fessel,
Robert W. Shafer,
Maurizio Zazzi,
Rolf Kaiser,
Thomas Lengauer
Publication year - 2009
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/597305
Subject(s) - set (abstract data type) , human immunodeficiency virus (hiv) , wilcoxon signed rank test , antiretroviral therapy , computer science , selection (genetic algorithm) , sequence (biology) , interpretation (philosophy) , task (project management) , artificial intelligence , computational biology , statistics , biology , viral load , virology , mathematics , engineering , genetics , mann–whitney u test , systems engineering , programming language
Expert-based genotypic interpretation systems are standard methods for guiding treatment selection for patients infected with human immunodeficiency virus type 1. We previously introduced the software pipeline geno2pheno-THEO (g2p-THEO), which on the basis of viral sequence predicts the response to treatment with a combination of antiretroviral compounds by applying methods from statistical learning and the estimated potential of the virus to escape from drug pressure.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom